Back to news
world

New Sunscreen Component Approved by FDA, Already Common Abroad

A new active ingredient, bemotrizinol, has received clearance from the U.S. Food and Drug Administration for use in sunscreens. This chemical compound has a long history of use in sun protection products across Europe and Asia.

6/25/2026, 5:01:30 AM

American consumers will soon have access to sunscreens featuring an ingredient widely adopted internationally for its effectiveness. The U.S. Food and Drug Administration (FDA) has given its approval for bemotrizinol, a chemical filter already prevalent in sun protection creams and lotions throughout Europe and Asia for many years. Experts in skin health have highlighted the benefits of this newly approved component. According to The New York Times, dermatologists believe bemotrizinol offers several advantages when compared to other sun filtering compounds currently available in the American market. Its inclusion is anticipated to enhance the protective qualities of sunscreens and potentially offer a broader spectrum of defense against harmful ultraviolet (UV) radiation. Bemotrizinol is known for its photostability, meaning it does not degrade quickly when exposed to sunlight, thereby maintaining its efficacy for longer periods. This characteristic is a significant improvement over some older sunscreen ingredients that can become less effective over time due to UV exposure. Furthermore, it is described as being effective against both UVA and UVB rays, providing comprehensive protection against sunburn, premature skin aging, and potentially reducing the risk of skin cancer. The introduction of this new filter could lead to more cosmetically elegant sunscreen formulations. Often, highly protective sunscreens can be thick or leave a white residue, which can deter regular use. Bemotrizinol’s properties might allow for lighter, less noticeable products that are more pleasant for daily application, encouraging greater adherence to sun protection guidelines. While this approval marks a step forward for the American sunscreen market, it also underscores the often-slow pace of regulatory processes compared to other regions. Consumers and health advocates have frequently called for the FDA to expedite the review of active ingredients already proven safe and effective abroad. This latest clearance could pave the way for other advanced sunscreen filters to enter the U.S. market in the future, bringing American products more in line with global standards.

Share